Real‐world treatment outcomes of medicines used in special situations (off‐label and compassionate use) in oncology and hematology: a retrospective study from a …
S Fontanals, A Esteve, A González, C Ibáñez… - Cancer …, 2023 - Wiley Online Library
Purpose Medicines in special situations (MSS) refer to off‐label or to unlicensed drugs
under investigation (compassionate use). Our objectives were to evaluate characteristics …
under investigation (compassionate use). Our objectives were to evaluate characteristics …
[HTML][HTML] How to develop new systemic treatments in ultra-rare cancers with high unmet needs? The case of alveolar soft-part sarcoma
Developing new drugs or generating evidence for existing drugs in new indications for ultra-
rare cancers is complex and carries a high-risk of failure. This gets even harder in ultra-rare …
rare cancers is complex and carries a high-risk of failure. This gets even harder in ultra-rare …
Real‐world treatment outcomes of immune checkpoint inhibitors used off‐label in oncology: A comprehensive cancer institution experience
S Fontanals, A Esteve, A González… - Pharmacology …, 2024 - Wiley Online Library
Off‐label use (OLU) is quite common in oncology due to the complexity of cancer and the
time‐consuming regulatory process. However, outcomes of OLU in cancer treatment remain …
time‐consuming regulatory process. However, outcomes of OLU in cancer treatment remain …
Comments on “Off-label despite high-level evidence: a clinical practice review of commonly used off-patent cancer medicines”
C Ibáñez, S Fontanals, R Mesia, A Clopés - ESMO open, 2023 - esmoopen.com
We read with interest the paper by Zarkavelis et al. 1 The authors identified a list of off-patent
low-cost cancer drugs remaining as off-label use (OLU) in specific settings, despite high …
low-cost cancer drugs remaining as off-label use (OLU) in specific settings, despite high …
[HTML][HTML] Эффективность применения противоопухолевых лекарственных препаратов «вне инструкции» в онкологии
ЕВ Карабина, ДД Сакаева… - Креативная хирургия и …, 2023 - cyberleninka.ru
Применение противоопухолевых лекарственных препаратов «вне инструкции» широко
распространено в современной онкологии. Потенциальные преимущества подобных …
распространено в современной онкологии. Потенциальные преимущества подобных …
[PDF][PDF] Farmácia Cruzeiro, Matosinhos
ABF Machado - 2023 - repositorio-aberto.up.pt
A fase final do Mestrado Integrado em Ciências Farmacêuticas é marcada pela aplicação
prática de todos os conhecimentos adquiridos através da realização de um estágio …
prática de todos os conhecimentos adquiridos através da realização de um estágio …
[PDF][PDF] Efficacy of Off-Label Use of Anticancer Drugs in Oncology
EV Karabina, DD Sakaeva, ON Lipatov - ХИРУРГИЯ и, 2023 - surgonco.ru
The off-label use of anticancer drugs is widespread in modern oncology. The potential
advantages of such prescriptions are associated with exceeding the expected clinical …
advantages of such prescriptions are associated with exceeding the expected clinical …
[PDF][PDF] ON-PATENT DRUG REPURPOSING
P Pantziarka, P Vandamme, G Bouche, L Meheus… - risingtide-foundation.org
The issues around financial and regulatory obstacles to the repurposing of off-patent/generic
medicines are well characterised in the academic literature and are familiar to policymakers …
medicines are well characterised in the academic literature and are familiar to policymakers …